CompletedNot Applicable

Dexamethasone Versus Nalbuphine as Adjuvants in Brachial Plexus Block

Egypt45 participantsStarted 2019-12-01

Plain-language summary

Brachial plexus block is a very reliable method of regional anesthesia for the upper limb. It achieves ideal operating conditions by producing complete muscular relaxation and stable intraoperative hemodynamics.However,Local anesthetics alone have a shorter duration of postoperative analgesia. Hence,various adjuvants have been added to local anesthetics to achieve quick, dense, and prolonged block. This study assess and compare the efficacy of dexamethasone or nalbuphine as adjuvants to local anesthetics in supraclavicular brachial plexus block for upper limb surgeries.

Who can participate

Age range21 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient acceptance. * American Society of Anesthesiologists (ASA) I and (ASA) II. * Age 21-60 years old. * Both gender. * BMI \< 30. * Accepted mental state of the patient. * Unilateral upper limb surgeries below the level of the shoulder. Exclusion Criteria: * Patient refusal. * Peripheral neuropathy. * Pathological coagulopathy. * Infection at the injection site. * History of active substance abuse. * Untreated pneumothorax. * Disturbed conscious level. * An allergy to local anesthetics or nalbuphine or dexamethasone. * Planned for receiving general anesthesia during the same operation for any cause.

What they're measuring

Duration of postoperative analgesia

Timeframe: First 24 hours after surgery

Trial details

NCT IDNCT04194320

SponsorZagazig University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-05-05

View on ClinicalTrials.gov More Anesthesia trials